SCHEMBL19863781

SCHEMBL19863781

COc1ccc(Cn2c(C=O)nc3cc(Cl)ccc32)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXA2R P21731 3/20 0.57
CCR2 P41597 1/20 0.53
ALDH1A1 P00352 4/20 0.52
HTT P42858 4/20 0.52
LMNA P02545 3/20 0.52
KDM4E B2RXH2 3/20 0.52
NPC1 O15118 2/20 0.52
HPGD P15428 2/20 0.52
NFKB1 P19838 2/20 0.52
RAB9A P51151 2/20 0.52
NFKB2 Q00653 2/20 0.52
RELA Q04206 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
GLA P06280 1/20 0.52
GAA P10253 1/20 0.52
NPY1R P25929 1/20 0.52
NPY2R P49146 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19863780 0.75 TBXA2R (0.52) TBXA2RCCR2ALDH1A1HTTLMNA
SCHEMBL376921 0.75 VDR (0.71) TBXA2RALDH1A1HTTLMNAKDM4E
SCHEMBL18890528 0.74 TP53 (0.55) TBXA2RCCR2ALDH1A1HTTLMNA
SCHEMBL28432753 0.73 VDR (0.67) ALDH1A1HTTLMNAKDM4ENPC1
SCHEMBL29870254 0.73 VDR (0.67) ALDH1A1HTTLMNAKDM4ENPC1
SCHEMBL31019833 0.73 CCR2 (0.58) TBXA2RCCR2ALDH1A1LMNAKDM4E
SCHEMBL22955887 0.73 TP53 (0.58) TBXA2RCCR2ALDH1A1HTTLMNA
SCHEMBL9681521 0.73 TBXA2R (1.00) TBXA2R
SCHEMBL4073539 0.72 VDR (0.45) TBXA2RALDH1A1HTTKDM4ENPC1
SCHEMBL26350330 0.72 TP53 (0.60) TBXA2RALDH1A1HTTLMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10577349-B2 Quinolinones as inhibitors of translation initiation complex Sanford Burnham Prebys Medical Discovery Institute (US) 2020-03-03 US disclosed
US-20180044324-A1 Quinolinones as Inhibitors of Translation Initiation Complex Sanford Burnham Prebys Medical Discovery Institute 2018-02-15 US disclosed
US-20180044324-A1 Quinolinones as Inhibitors of Translation Initiation Complex Sanford Burnham Prebys Medical Discovery Institute 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044324-A1 Quinolinones as Inhibitors of Translation Initiation Complex EIF4E, EIF4A1, EIF4A2 TBXA2R 3849/4885CCR2 4650/4885ALDH1A1 4269/4885
US-10577349-B2 Quinolinones as inhibitors of translation initiation complex EIF4E, EIF4A1, EIF4A2 TBXA2R 3849/4885CCR2 4650/4885ALDH1A1 4269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.